Effect of voriconazole on a corneal abscess caused by fusarium

Acta Ophthalmologica Scandinavica

Volumn 82, Issue 6, 2004, Pages 762-764

  Polizzi, Anna ^a   Siniscalchi, Cristina ^a   Mastromarino, Antonio ^a   Saccà, Sergio Cladio ^a,b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Corneal abscess therapy; Fusarium solani; Keratomycosis; Voriconazole

Indexed keywords

ACETAZOLAMIDE; AMPHOTERICIN B; CHLORAMPHENICOL; DEXAMETHASONE; DICLOFENAC; FLUCONAZOLE; OFLOXACIN; TOBRAMYCIN; VORICONAZOLE;

ABSCESS; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; CASE REPORT; CORNEA TRANSPLANTATION; CORNEA ULCER; DISEASE SEVERITY; DRUG EFFICACY; FUSARIUM SOLANI; GRAFT INFECTION; HUMAN; KERATOMYCOSIS; MALE; MICROBIOLOGICAL EXAMINATION; PENETRATING KERATOPLASTY; PRESCRIPTION; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT FAILURE; TREATMENT OUTCOME; VEGETATION;

ABSCESS; ANTIFUNGAL AGENTS; CORNEAL DISEASES; EYE INFECTIONS, FUNGAL; FUSARIUM; HUMANS; KERATOPLASTY, PENETRATING; MALE; MIDDLE AGED; MYCOSES; PYRIMIDINES; TRIAZOLES;

EID: 11244265944     PISSN: 13953907     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0420.2004.00366.x     Document Type: Article

References (11)

1. Alldredge OC & Krachmer JH (1981): Clinical types of corneal transplant rejection: their manifestations, frequency, preoperative correlates and treatment. Arch Ophthalmol 99: 599-604.
2. Espinel-Ingroff A, Boyle K & Sheehan DJ (2001): In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: review of the literature. Mycopathologia 150: 101-15.
3. Goldblum D, Frueh BE, Zimmerli S & Bohnke M (2000): Treatment of postkeratitis fusarium endophthalmitis with amphotericin B lipid complex. Cornea 19: 853-856.
4. Hoffman HI & Rathbun RC (2002): Review of the safety and efficacy of voriconazole. Expert Opin Invest Drugs 11: 409-412.
5. Johns KJ & O'Day DM (1988): Pharmacologic management of keratomycoses. Surv Ophthalmol 33: 178-88.
6. Marco F, Pfaller MA, Messer SA & Jones RN (1998): Antifungal activity of a new triazole, voriconazole (UK-109, 496), compared with three other antifungal agents tested against clinical isolates of filamentous fungi. Med Mycol 36: 433-436.
7. Plotkin J, Reynaud A & Okumoto M (1971): Cytologic study of herpetic keratitis. Arch Ophthalmol 85: 597-599.
8. Reis A, Sundmacher R, Tintelnot K, Agostini H, Jensen HE & Althaus C (2000): Successful treatment of ocular invasive mould infection (fusariosis) with the new antifungal agent voriconazole. Br J Ophthalmol 84: 932-933.
9. Rosa RH, Miller D & Alfonso EC (1994): The changing spectrum of fungal keratitis in South Florida. Ophthalmology 101: 1005-1013.
10. Walsh TJ, Viviani MA, Arathoon E, Chiou C, Ghannoum M, Groll AH & Odds FC (2000): New targets and delivery systems for antifungal therapy. Med Mycol 38 (1): 335-347.
11. Yee RW, Cheng CJ, Meenakshi S, Ludden TM, Wallace JE & Rinaldi MG (1997): Ocular penetration and pharmacokinetics of topical fluconazole. Cornea 16: 64-71.